Market Cap ₹3 Cr.
Stock P/E -53.5
P/B 0.2
Current Price ₹1.8
Book Value ₹ 8.8
Face Value 10
52W High ₹2.7
Dividend Yield 0%
52W Low ₹ 1.6
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Jun 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Profit | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
Adjusted Earnings Per Share | -0 | -0 | -0 | -0 | -0 | -0.1 | -0 | -0 | -0 | 0 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 |
Operating Profit | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -1 | -0 | -0 | -1 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -1 | -0 | -0 | -1 | 0 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -1 | -0 | -0 | -1 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -1 | -0 | -0 | -1 | 0 |
Adjusted Earnings Per Share | 0 | 0 | 0 | 0 | 0 | -0 | -0.1 | -0.7 | -0.1 | -0.1 | -0.9 | 0 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 0% | 0% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -25% | 31% | 36% | NA% |
ROE Average | -9% | -4% | -4% | -2% |
ROCE Average | -9% | -4% | -4% | -2% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 15 | 15 | 14 | 13 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 17 | 17 | 17 | 17 | 17 | 16 | 16 | 15 | 15 | 14 | 13 |
Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 15 | 15 | 15 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 13 |
Total Current Assets | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 0 | 0 | 0 | 0 |
Total Assets | 17 | 17 | 17 | 17 | 17 | 16 | 16 | 15 | 15 | 14 | 13 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | 0 | -0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 |
Cash Flow from Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
Cash Flow from Financing Activities | -0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 |
Net Cash Inflow / Outflow | 0 | -0 | -0 | -0 | 0 | -0 | 0 | -0 | 0 | 0 | -0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0 | 0 | 0 | 0 | 0 | -0.04 | -0.09 | -0.69 | -0.1 | -0.13 | -0.87 |
CEPS(Rs) | 0 | 0 | 0 | 0 | 0 | -0.04 | -0.09 | -0.69 | -0.1 | -0.13 | -0.87 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 0 | 0 | 0 | 0 | 10.68 | 10.63 | 10.54 | 9.85 | 9.75 | 9.62 | 8.75 |
Core EBITDA Margin(%) | -7.05 | 2.62 | -0.18 | -203.3 | -226.21 | -103.12 | 0 | 0 | 0 | 0 | 0 |
EBIT Margin(%) | 5.75 | 5.64 | 6.32 | 10.51 | 11.29 | -94.88 | 0 | 0 | 0 | 0 | 0 |
Pre Tax Margin(%) | 5.75 | 5.64 | 6.3 | 10.28 | 11.16 | -95.05 | 0 | 0 | 0 | 0 | 0 |
PAT Margin (%) | 3.96 | 3.89 | 4.29 | 6.8 | 7.81 | -95.05 | 0 | 0 | 0 | 0 | 0 |
Cash Profit Margin (%) | 4.57 | 4.4 | 4.29 | 6.8 | 7.81 | -95.05 | 0 | 0 | 0 | 0 | 0 |
ROA(%) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | -0.35 | -0.84 | -6.6 | -1 | -1.34 | -9.39 |
ROE(%) | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | -0.36 | -0.86 | -6.72 | -1 | -1.34 | -9.45 |
ROCE(%) | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | -0.35 | -0.84 | -6.61 | -0.99 | -1.34 | -9.42 |
Receivable days | 4526.44 | 4428.07 | 4471.25 | 9485.03 | 0 | 6587.14 | 0 | 0 | 0 | 0 | 0 |
Inventory Days | 3593.51 | 3386.57 | 3213.24 | 6544.91 | 7711.59 | 5127.8 | 0 | 0 | 0 | 0 | 0 |
Payable days | 0 | 0 | 0 | 0 | -21.47 | 105.29 | 0 | 3.24 | 0 | 0 | 0 |
PER(x) | 0 | 0 | 0 | 0 | 1513.54 | 0 | 0 | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0.3 | 0 | 0.04 | 0.06 | 0.08 | 1.22 | 0.26 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 175.13 | 168.31 | 163 | 338.78 | 135.99 | 249.82 | 0 | 2217.57 | 0 | 0 | 0 |
EV/Core EBITDA(x) | 2757.54 | 2736.56 | 2577.75 | 3223.65 | 1204.86 | -263.31 | -7.8 | -0.9 | -7.71 | -90.02 | -2.6 |
Net Sales Growth(%) | 93.31 | 4.06 | 3.3 | -51.37 | -13.05 | 53.17 | -100 | 0 | -100 | 0 | 0 |
EBIT Growth(%) | 4.23 | 2.15 | 15.81 | -19.18 | -6.61 | -1387.57 | -134.15 | -655.17 | 85.85 | -33.54 | -569.02 |
PAT Growth(%) | 21.3 | 2.19 | 13.79 | -22.91 | -0.13 | -1964.36 | -135.45 | -650.16 | 85.72 | -32.88 | -567.68 |
EPS Growth(%) | 0 | 0 | 0 | 0 | 0 | -1964.3 | -135.46 | -650.12 | 85.73 | -32.92 | -567.77 |
Debt/Equity(x) | 0.03 | 0.03 | 0.03 | 0.04 | 0.06 | 0.02 | 0.03 | 0 | 0 | 0 | 0 |
Current Ratio(x) | 9.92 | 9.13 | 8.35 | 12.7 | 13.23 | 150.52 | 27.41 | 40.4 | 14.28 | 20.87 | 0.45 |
Quick Ratio(x) | 5.73 | 5.41 | 5.05 | 8.27 | 8.91 | 89.06 | 16.42 | 40.4 | 14.28 | 20.87 | 0.45 |
Interest Cover(x) | 0 | 0 | 239.22 | 45.24 | 88.18 | -562.18 | -333.28 | -1507.36 | -100.55 | -201.83 | -339.25 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.19 | 0 | 0.89 | 0 | 0 | 0 | 0 |
# | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 21.87 | 21.87 | 21.87 | 21.87 | 21.87 | 18.58 | 0.02 | 0.02 | 0.02 | 0.02 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 78.13 | 78.13 | 78.13 | 78.13 | 78.13 | 81.42 | 99.98 | 99.98 | 99.98 | 99.98 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.28 | 0 | 0 | 0 | 0 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 1.17 | 1.17 | 1.17 | 1.17 | 1.17 | 1.22 | 1.5 | 1.5 | 1.5 | 1.5 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About